Intravitreal injection technique

Seminars in Ophthalmology

Volumn 26, Issue 3, 2011, Pages 104-113

  Doshi, Rishi R ^a   Bakri, Sophie J ^b   Fung, Anne E ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

Author keywords

anesthesia; drug therapy; intraocular injection; intravitreous injection

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIGLAUCOMA AGENT; ARTIFICIAL TEAR; BEVACIZUMAB; LIDOCAINE; LOCAL ANESTHETIC AGENT; OXYBUPROCAINE; PEGAPTANIB; PHENYLEPHRINE; POVIDONE IODINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RANIBIZUMAB; TETRACAINE; TRIAMCINOLONE; TROPICAMIDE; WARFARIN;

AMBULATORY CARE; ANTIANGIOGENIC THERAPY; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTICOAGULANT THERAPY; APPLICATION SITE DISCOMFORT; ASEPSIS; CORTICOSTEROID THERAPY; COTTON; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG POTENTIATION; DRUG SAFETY; DRUG WITHDRAWAL; ENDOPHTHALMITIS; EYE EXAMINATION; HEART INFARCTION; HUMAN; INFECTION RATE; INJECTION SITE PAIN; INTRAOCULAR PRESSURE; INTRAVITREAL DRUG ADMINISTRATION; MASK; MEDICAL EDUCATION; MYDRIASIS; NEEDLE; OPERATING ROOM; PATIENT PARTICIPATION; PRIORITY JOURNAL; RETINA ARTERY; RETINA BLOOD FLOW; REVIEW; RISK BENEFIT ANALYSIS; STROKE; SURGEON; SURGICAL DRAPE; TOPICAL ANESTHESIA;

CLINICAL PROTOCOLS; HUMANS; INTRAVITREAL INJECTIONS; OPHTHALMOLOGY; PHARMACEUTICAL PREPARATIONS;

EID: 79957594441     PISSN: 08820538     EISSN: 17445205     Source Type: Journal    
DOI: 10.3109/08820538.2010.541318     Document Type: Review

References (48)

1. Ohm J. Über die Behandlung der Netzhautablösung durch operative Entleerung der subretinalen Flüssigkeit und Einspritzen vom Luft in den Glaskörper. Graefe Arch Klin Ophthalmol 1911;79:442-450.
2. Schneider J, Frankel SS. Treatment of late postoperative intraocular infections with intraocular injection of penicillin. Arch Ophthalmol 1947;37:304-307.
3. FDA website: http://www.accessdata.fda.gov/Scripts/cder/DrugsatFDA/4. Fung AE, Rosenfeld PJ, Reichel E. The International Intravitreal Bevacizumab Safety Survey: Using the internet to assess drug safety worldwide. Br J Ophthalmol 2006;90(11):1344-9. (Pubitemid 44702055)
4. Ip MS, Scott IU, VanVeldhuisen PC, Oden NL, Blodi BA, Fisher M, Singerman LJ, Tolentino M, Chan CK, Gonzalez VH. Score Study Research Group. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. Arch Ophthalmol 2009;127(9):1101-14.
5. Brown DM, Campochiaro PA, Singh RP, Li Z, Gray S, Saroj N, Rundle AC, Rubio RG, Murahashi WY, CRUISE Investigators. Ranibizumab for macular edema following central retinal vein occlusion six-month primary end point results of a phase III study. Ophthalmology 2010;117(6):1124-33.
6. Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR. VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for neovascular age- related macular degeneration. N Engl J Med 2004;351:2805-16.
7. Jager RD, Aiello LP, Patel SC, Cunningham ET Jr. Risks of intravitreous injection: Acomprehensive review. Retina 2004;24(5):676-98. (Pubitemid 39391758)
8. Schwartz SG, Flynn HW, Scott IU. Endophthalmitis after intravitreal injections. Expert Opin Pharmacother 2009;10(13):2119-26.
9. Fintak DR, Shah GK, Blinder KJ, Regillo CD, Pollack J, Heier JS, Hollands H, Sharma S. Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab. Retina 2008;28(10):1395-9.
10. Fung AE, Bhisitkul RB. Safety monitoring with ocular antivascular endothelial growth factor therapies. Br J Ophthalmol 2008;92(12):1573-4.
11. Aiello LP, Brucker AJ, Chang S, Cunningham ET Jr, D'Amico DJ, Flynn HW Jr, Grillone LR, Hutcherson S, Liebmann JM, O'Brien TP, Scott IU, Spaide RF, Ta C, Trese MT. Evolving guidelines for intravitreous injections. Retina 2004;24(5 Suppl):S3-19. (Pubitemid 39391785)
12. Anijeet DR, Hanson RJ, Bhagey J, Bates RA. National survey of the technique of intravitreal triamcinolone injection in the United Kingdom. Eye (Lond) 2007;21(4):480-6. (Pubitemid 46564139)
13. Charles S, Rosenfeld PJ, Gayer S. Medical consequences of stopping anticoagulant therapy before intraocular surgery or intravitreal injections. Retina 2007;27(7):813-5. (Pubitemid 47479373)
14. Meyer CH, Callizo J, Mennel S, Kussin A. Perioperative management of anticoagulated patients undergoing repeated intravitreal injections. Arch Ophthalmol 2007;125:994. (Pubitemid 47076454)
15. Isenberg SJ, Apt L, Yoshimori R, Khwarg S. Chemical preparation of the eye in ophthalmic surgery. IV. Comparison of povidone-iodine on the conjunctiva with a prophylactic antibiotic. Arch Ophthalmol 1985;103(9):1340-2. (Pubitemid 15230623)
16. Miller JJ, Scott IU, Flynn HW Jr, Smiddy WE, Newton J, Miller D. Acute-onset endophthalmitis after cataract surgery (2000-2004): incidence, clinical settings, and visual acuity outcomes after treatment. Am J Ophthalmol 2005;139(6):983-987.
17. Bylsma G, Guymer R, Qureshi S, Gin T, Allen P, Madhok P, McCombe M, Harper A. Intravitreous injections. Clin Experiment Ophthalmol 2006;34(4):388-90.
18. Ziemssen F, Wiedemann P, Kampik A, Holz F, Bartz-Schmidt KU. [Intravitreal injections of medications in Germany. Contract situation and legal conditions]. Ophthalmologe 2009;106(5):465-70.
19. Schmidt-Erfurth UM, Richard G, Augustin A, Aylward WG, Bandello F, Corcòstegui B, Cunha-Vaz J, Gaudric A, Leys A, Schlingemann RO; European Society for Retina Specialists' Guidelines Committee (EURETINA). Guidance for the treatment of neovascular age-related macular degeneration. Acta Ophthalmol Scand 2007;85:486-494. (Pubitemid 47163109)
20. Bakri SJ, Pulido JS, McCannel CA, Hodge DO, Diehl N, Hillemeier J. Immediate intraocular pressure changes following intravitreal injections of triamcinolone, pegaptanib, and bevacizumab. Eye (Lond) 2009;23(1):181-5.
21. Cintra LP, Lucena LR, Da Silva JA, Costa RA, Scott IU, Jorge R. Comparative study of analgesic effectiveness using three different anesthetic techniques for intravitreal injection of bevacizumab. Ophthalmic Surg Lasers Imaging 2009;40(1):13-8.
22. Intravitreal Injection Survey. Anti-infection procedures are still evolving. Retin Physician 2006. www.retinalphysician.com/article.aspx?article= &loc=archive\2006\may\0506055.htm. Accessed December 8, 2009.
23. Knecht PB, Michels S, Sturm V, Bosch MM, Menke MM. Tunnelled versus straight intravitreal injection: Intraocular pressure changes, vitreous reflux, and patient discomfort. Retina 2009;29(8):1175-81.
24. Fung AE, Lalwani GA, Rosenfeld PJ, Dubovy SR, Michels S, Feuer WJ, Puliafito CA, Davis JL, Flynn HW Jr, Esquiabro M. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol 2007;143(4):566-83.
25. Kozak I, Cheng L, Freeman WR. Lidocaine gel anesthesia for intravitreal drug administration. Retina 2005;25(8):994-8. (Pubitemid 44735096)
26. Page MA, Fraunfelder FW. Safety, efficacy, and patient acceptability of lidocaine hydrochloride ophthalmic gel as a topical ocular anesthetic for use in ophthalmic procedures. Clin Ophthalmol 2009;3:601-9.
27. Boden JH, Myers ML, Lee T, Bushley DM, Torres MF. Effect of lidocaine gel on povidone-iodine antisepsis and microbial survival. J Cataract Refract Surg 2008;34(10):1773-1775.
28. Park HS, Kim MS. The inflammatory potential of surgical glove lubricants: Biosorb, Keoflo, calcium carbonate and Hydrocote after intravitreal injection. Korean J Ophthalmol 1997;11:51-59.
29. Namdari H, Kintner K, Jackson BA, Namdari S, Hughes JL, Peairs RR, Savage DJ. Abiotrophia species as a cause of endophthalmitis following cataract extraction. J Clin Microbiol 1999;37(5):1564-6. (Pubitemid 29187835)
30. Speaker MG, Menikoff JA. Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology 1991;98:1769-75.
31. Lachapelle JM. Allergic contact dermatitis from povidone- iodine: A re-evaluation study. Contact Dermatitis 2005;52(1):9-10.
32. Barkana Y, Almer Z, Segal O, Lazarovitch Z, Avni I, Zadok D. Reduction of conjunctival bacterial flora by povidoneiodine, ofloxacin and chlorhexidine in an outpatient setting. Acta Ophthalmol Scand 2005;83(3):360-3. (Pubitemid 40872512)
33. Kiffney GT, Hattaway AC. Povidone-iodine as an ophthalmic antiseptic. Surg Forum 1966;17:434-435.
34. Ferguson AW, Scott JA, McGarigan J et al. Comparison of 5% povidone-iodine solution against 1% povidone iodine solution in preoperative cataract surgery antisepsis: A prospective randomised double blind study. Br J Ophthalmol 2003;87:163-167. (Pubitemid 36152742)
35. Safar A, Dellimore MC. The effect of povidone iodine flush versus drops on conjunctival colonization before intravitreal injections. Int Ophthalmol 2007;27(5):307-12. (Pubitemid 47377475)
36. Pulido JS, Zobitz ME, An K-N. Scleral penetration force requirements for commonly used intravitreal needles. Eye 2007;21:1210-1211. (Pubitemid 47382149)
37. Bakri SJ, Ekdawi NS. Intravitreal silicone oil droplets after intravitreal drug injections. Retina 2008;28(7): 9961-001.
38. Scott IU, Oden NL, VanVeldhuisen PC, Ip MS, Blodi BA, Antoszyk AN. SCORE Study Investigator Group. SCORE Study Report 7: Incidence of intravitreal silicone oil droplets associated with staked-on vs luer cone syringe design. Am J Ophthalmol 2009;148(5):725-732.e7.
39. Peyman GA, Lad EM, Moshfeghi DM. Intravitreal injection of therapeutic agents. Retina 2009;29(7):875-912.
40. Carsten HM, Fung AE, Saxena S, Frank GH. Steps for a Safe Intravitreal Injection Technique: A look at how European and American approaches compare. Retinal Physician 2009 Jul.
41. Friedrich S, Cheng YL, Saville B. Drug distribution in the vitreous humor of the human eye: The effects of intravitreal injection position and volume. Curr Eye Res 1997;16:663-669. (Pubitemid 27322718)
42. Rodrigues EB, Meyer CH, Grumann A Jr, Shiroma H, Aguni JS, Farah ME. Tunneled scleral incision to prevent vitreal reflux after intravitreal injection. Am J Ophthalmol 2007;143(6):1035-7. (Pubitemid 46764639)
43. Chen SD, Mohammed Q, Bowling B, Patel CK. Vitreous wick syndrome-A potential cause of endophthalmitis after intravitreal injection of triamcinolone through the pars plana. Am J Ophthalmol 2004;137(6):1159-60.
44. Hubschman JP, Coffee RE, Bourges JL, Yu F, Schwartz SD. Experimental model of intravitreal injection techniques. Retina 2010;30(1):167-73.
45. Bakri SJ, Risco M, Edwards AO, Pulido JS. Bilateral simultaneous intravitreal injections in the office setting. Am J Ophthalmol 2009;148(1):66-9.
46. Hayreh SS, Zimmerman MB, Kimura A, Sanon A. Central retinal artery occlusion. Retinal survival time. Exp Eye Res 2004;78:723-36. (Pubitemid 38183351)
47. Kim JE, Mantravadi AV, Hur EY, Covert DJ. Short-term intraocular pressure changes immediately after intravitreal injections of anti-vascular endothelial growth factor agents. Am J Ophthalmol 2008;146(6):930-4.
48. Hosseini H, Razeghinejad MR. Anterior ischemic optic neuropathy after intravitreal injection of bevacizumab. J Neuroophthalmol 2009;29(2):160-1.